low-dose chest ct for diagnosing and assessing the extent
TRANSCRIPT
RESEARCH ARTICLE
Low-dose chest CT for diagnosing and
assessing the extent of lung involvement of
SARS-CoV-2 pneumonia using a semi
quantitative score
Thomas Leger1, Alexis Jacquier1,2, Pierre-Antoine Barral1, Maxime Castelli1,
Julie FinanceID3, Jean-Christophe Lagier3,4, Matthieu Million3,4, Philippe Parola3,5,
Philippe Brouqui3,4, Didier Raoult3,4, Axel Bartoli1,2, Jean-Yves Gaubert1,6,7,
Paul HabertID1,6,7*
1 Department of Radiology, La Timone Hospital, Assistance Publique des Hopitaux de Marseille, Marseille,
France, 2 Aix-Marseille Universite, UMR 7339, CNRS, Centre de Resonance Magnetique Biologique et
Medicale–Centre d’Exploration Metaboliques par Resonance Magnetique, Assistance Publique—Hopitaux
de Marseille, Marseille, France, 3 IHU-Mediterranee Infection, Marseille, France, 4 Aix Marseille Univ, IRD,
APHM, MEPHI, Marseille, France, 5 Aix Marseille Univ, IRD, APHM, SSA, VITROME, Marseille, France,
6 Aix Marseille Univ, LIIE, Marseille, France, 7 Aix Marseille Univ, CERIMED, Marseille, France
Abstract
Objectives
The purpose is to assess the ability of low-dose CT (LDCT) to determine lung involvement in
SARS-CoV-2 pneumonia and to describe a COVID19-LDCT severity score.
Materials and methods
Patients with SARS-CoV-2 infection confirmed by RT-PCR were retrospectively analysed.
Clinical data, the National Early Warning Score (NEWS) and imaging features were
recorded. Lung features included ground-glass opacities (GGO), areas of consolidation and
crazy paving patterns. The COVID19-LDCT score was calculated by summing the score of
each segment from 0 (no involvement) to 10 (severe impairment). Univariate analysis was
performed to explore predictive factor of high COVID19-LDCT score. The nonparametric
Mann-Whitney test was used to compare groups and a Spearman correlation used with
p<0.05 for significance.
Results
Eighty patients with positive RT-PCR were analysed. The mean age was 55 years ± 16, with
42 males (53%). The most frequent symptoms were fever (60/80, 75%) and cough (59/80,
74%), the mean NEWS was 1.7±2.3. All LDCT could be analysed and 23/80 (28%) were
normal. The major imaging finding was GGOs in 56 cases (67%). The COVID19-LDCT
score (mean value = 19±29) was correlated with NEWS (r = 0.48, p<0.0001). No symptoms
were risk factor to have pulmonary involvement. Univariate analysis shown that dyspnea,
PLOS ONE
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 1 / 12
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Leger T, Jacquier A, Barral P-A, Castelli
M, Finance J, Lagier J-C, et al. (2020) Low-dose
chest CT for diagnosing and assessing the extent
of lung involvement of SARS-CoV-2 pneumonia
using a semi quantitative score. PLoS ONE 15(11):
e0241407. https://doi.org/10.1371/journal.
pone.0241407
Editor: Wenbin Tan, University of South Carolina,
UNITED STATES
Received: June 16, 2020
Accepted: October 12, 2020
Published: November 3, 2020
Copyright: © 2020 Leger et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All relevant data are
within the paper and its Supporting Information
files.
Funding: The author(s) received no specific
funding for this work.
Competing interests: The authors have declared
that no competing interests exist.
Abbreviations: ARDS, acute respiratory distress
syndrome; COVID19, coronavirus disease 2019;
high respiratory rate, hypertension and diabetes are associated to a COVID19-LDCT score
superior to 50.
Conclusions
COVID19-LDCT score did correlate with NEWS. It was significantly different in the clinical
low-risk and high-risk groups. Further work is needed to validate the COVID19-LDCT score
against patient prognosis.
Introduction
The outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), that began
in Wuhan, China, spread worldwide, and is now in the ascending phase of the epidemic in
Europe [1]. SARS-CoV-2 is responsible for coronavirus disease 2019 (COVID-19) pneumonia.
Respiratory involvement has a wide variety of clinical features, ranging from simple nasal con-
gestion to pulmonary failure [2]. Moreover, many patients remain asymptomatic but a vector
of the disease, allowing the epidemic to spread easily.
The main problem of COVID-19 pneumonia is the risk of saturation of our health system
due to an uncommonly massive inflow of patients requiring intensive care. Patient selection is
therefore essential in order for health care practitioners to focus on patients with comorbidities
and on severe cases. This selection is currently essentially based on clinical criteria.
Reverse-transcription polymerase chain reaction (RT-PCR) is currently the standard of ref-
erence for diagnosis of COVID 19 pneumonia. Chest x-ray might be replaced by low-dose
computed tomography (LDCT) in COVID-19 to assess lung involvement. Thus, computed
tomography (CT) has an important role in the management of patients, both for early screen-
ing and diagnosis and for establishing disease severity [3–5].
COVID-19 pneumonia lung lesions are now well characterized: they are typically asymmet-
ric, with ground-glass opacity (GGO) lesions or, less commonly, pulmonary areas of consoli-
dation, they have a peripheral distribution, and they preferentially affect the lower territories
[6]. It seems that there is a continuum in the lung lesions visible on CT scans, first with GGO
lesions; then reticulations appear with crazy-paving patterns, parenchymatous areas of consoli-
dation and finally, healing [7, 8].
The objective is to evaluate the ability of (LDCT) to analyze well-known imaging abnormal-
ities as well as to establish a COVID19-LDCT score reflecting disease severity and correlate it
with clinical risk scores to allow better selection and follow-up of patients.
Material and methods
Study design
The first 80 patients with a diagnosis of COVID-19 pneumonia confirmed by RT-PCR method
[9] were included in this single-centre retrospective study conducted from the 13th to the 20th
of March 2020. The inclusion criteria and patient enrolment included all consecutive patients
presenting to the department of infectious disease for 12 consecutive days with a diagnosis of
COVID-19 confirmed by RT-PCR. All patients underwent LDCT. The protocol was approved
by the local institutional review board: institut hospitalo-universitaire mediteranee-infection
N˚:2020–0012. The exclusion criteria was protocol refusal. For each patient, the following clin-
ical parameters were recorded: age, sex, date of first symptoms, date of chest CT scan, delay
between the first symptom and chest CT scan, fever, cough, dyspnea, diarrhea, myalgia,
PLOS ONE Low-dose chest CT scoring for SARS-CoV-2 pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 2 / 12
GGO, ground-glass opacity; LDCT, low-dose chest
CT; NEWS, national early warning score; RT-PCR,
real-time reverse transcription-polymerase chain
reaction; SARS-CoV-2, severe acute respiratory
syndrome coronavirus 2.
rhinorrhea, abnormalities at lung auscultation, temperature, heart rate, blood pressure, respi-
ratory rate, oxygen saturation, and oxygen needed. Medical history parameters were recorded
as follows: heart disease, tobacco use, COPD, asthma, diabetes, obesity, sleep apnea syndrome,
oncologic status and immunosuppression status. The National Early Warning Score (NEWS)
was calculated for each patient using respiratory rate, oxygen saturation, supplemental oxygen
needed, temperature, systolic blood pressure, heart rate, and AVPU score, as described previ-
ously [10]. The NEWS determines the degree of illness of a patient and prompts critical care
intervention. According to previously published data, patients were divided into the following
two groups based on the NEWS in order to compare the radiological data in these populations:
low NEWS (NEWS� 4) and high NEWS (NEWS > 4) groups [10].
Equipment
All departments had to be reorganized in response to the increase in COVID-19 pneumonia,
and CT scans were dedicated for this activity with a specific patient circuit. Technicians and
workers in contact with COVID19 patients took all preventative means to protect themselves
against transmission of the virus following the local institutional recommendations. A video
was performed in our department to highlight the work of radiology technicians and available
on https://youtu.be/mI-L_ZrL__U.
LDCT
All patients underwent LDCT on the same system (Revolution EVO—GE Healthcare). All
LDCT scans were unenhanced in profound and maximal inspiration with the following
parameters: detector collimation: 0.625 mm; field of view: 500 mm; matrix: 512x512; pitch:
1.375; gantry speed 0.35s; 120 KV; 45 mAs; and reconstructed slice thickness 1.2mm. All imag-
ing data were reconstructed using high resolution and standard algorithms. LDCT data were
sent directly to a picture archiving and communicating system. Monitors were used to view
both mediastinal (width, 400 HU; level, 20 HU) and lung (width, 1500 HU; level, -2700 HU)
windows. The pre-established top anatomic border was the lower part of the neck. The pre-
established anatomic bottom boundary was the estimated location of the adrenal glands below
the costophrenic angle.
All LDCT scans were analysed by a single chest radiologist with more than 25 years of expe-
rience in chest imaging (JYG). All abnormalities were described according to the Fleischner
glossary [11]. The main features encountered during SARS-CoV-2 have been described else-
where as GGOs, areas of consolidation, crazy paving patterns, and extension of these lesions
might evolve dramatically to acute respiratory distress syndrome (ARDS). The type and distri-
bution of the lesions were analysed [12, 13].
COVID19-LDCT score
LDCT scores were used to quantify the extent of lung abnormalities. The score was obtained
by summing the notes attributed to each segment. The extent of the lesions of COVID-19
pneumonia was visually classified into 4 types for each segment: lack of lesions and mini-
mal, intermediate and severe involvement. Lack of involvement was defined as a normal
pattern and was equivalent to 0. Minimal involvement was defined as the presence of maxi-
mum 10 secondary lobules of any features and was equivalent to 1. Intermediate involve-
ment was defined as less than 50% involvement of the segment by any features and was
equivalent to 4. Severe involvement was defined as more than 50% involvement of the seg-
ment by any feature and was equivalent to 10. The score was obtained by summing the
score of all segments for the right and left lungs, with the result ranking between 0
PLOS ONE Low-dose chest CT scoring for SARS-CoV-2 pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 3 / 12
corresponding to a normal chest CT and 200 if all segments had involvement of more than
50% of their volume (Fig 1). Chest-CT was considered with high impairment if the global
score was superior to 50, we compared two groups to assess if clinical data could be predic-
tor of severe involvement of lung parenchyma.
PCR assay
Virological diagnosis of SARS-CoV-2 infection was performed using a sample nasopharyngeal
swabs with an hydrolysis probe-based real-time reverse transcription-PCR system that targets
the envelope (E) protein-encoding gene [9, 14].
Statistical analysis
Quantitative data were expressed as mean, standard deviation and range. Qualitative data were
expressed raw numbers, proportions and percentages. The differences between the variables
were compared by the Chi 2 or Fischer test for qualitative variables and by U Mann-Whitney
for quantitative variables. The relationship between quantitative parameters was examined
with Spearman correlation test. Binary logistic regression analysis was used to test the relation-
ships between COVID-LDCT score and clinically relevant variables. A value of p<0.05 indi-
cated a statistically significant difference. Statistical analysis was performed on XLSTAT v19.1
(Addinsoft, New York, USA).
Results
Patients
Between the 13th and the 20th of March 2020 the first 80 patients with positive RT-PCR results
for COVID-19 were enrolled in a single center. All data could be recorded for all patients. The
mean age of the population was 55 years ± 16, with 42 males and 38 females (47%). For 75 of
the patients (94%), the medical consultation was carried out following a symptom; for the oth-
ers, it followed close contact with an affected case.
Fig 1. Illustration of how to calculate the COVID19-LDCT score. A. The triangle with red borders shows the 6th
segment of the left lung with a unique GGO corresponding to minimal impairment. B. The triangle with red borders
shows the 6th segment of the right lung with GGO inside involving 50% of the segment corresponding to intermediate
impairment. C. Two triangles showing the 10th and the 9th segments of the left lung, where the extent of GGO
was> 50% and 50%, corresponding to severe and intermediate impairment, respectively.
https://doi.org/10.1371/journal.pone.0241407.g001
PLOS ONE Low-dose chest CT scoring for SARS-CoV-2 pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 4 / 12
Clinical and LDCT Data
Initially the most frequent symptoms were fever in 60 patients (75%) and cough in 59 patients
(74%). Myalgia, rhinorrhea, dyspnea and diarrhea were less frequent and were found in 35
(44%), 18 (23%), 11 (14%) and 11 (14%) patients, respectively. Lung auscultation abnormalities
were found in only 14 patients (18%). Five patients needed resuscitation for an ARDS 5/80 (6%).
At the first examination before LDCT, the mean temperature was 37.5˚C ± 0.9, heart rate
was 83 bpm ± 13, systolic blood pressure was 134 mmHg ± 21, diastolic blood pressure was 76
mmHg ± 14, respiratory rate was 19/min ± 5 and oxygen saturation was 97% ± 2. The mean
NEWS was 1.7 ± 2.3 (Table 1).
The delay between the first symptom and the LDCT scan was 7 ± 4 days. The dose-length
product mean was 41.7 mGy.cm ± 15.5. All patients could have their images analysed 80/80
Table 1. Characteristics of the population and clinical data.
Total Population
Number of patients 80
Demographic data
Male 42/80; 53%
Female 38/80; 47%
Age (years) 55 ± 16 [17–89]
Delay between symptoms and CT (days) 7 ± 4 [2–21]
Symptomatic patients 75/80; 94%
Asymptomatic patients 5/80; 6%
Clinical data
Fever, chills 60/80; 75%
Cough 59/80; 74%
Dyspnea 11/80; 14%
Myalgia 35/80; 44%
Diarrhea 11/80; 14%
Rhinorrhea 18/80; 23%
Auscultation abnormalities 14/80; 18%
Temperature (˚C) 37.5 ± 0.9 [36–40]
Heart rate (bpm) 83 ± 13 [53–110]
Systolic blood pressure (mmHg) 134 ± 21 [100–219]
Diastolic blood pressure (mmHg) 76 ± 14 [11–120]
Respiratory rate (/min) 19 ± 5 [8–36]
Oxygen saturation (%) 97 ± 2 [91–100]
Oxygen needed 10/80; 13%
Heart disease 9/80; 11%
Tobacco use 10/80; 12%
COPD 3/80; 4%
Asthma 8/80; 10%
Sleep apnea syndrome 6/80; 7%
Oncologic disease 6/80; 7%
Diabetes 8/80; 10%
Note: The qualitative variables are expressed as figures with percentages, and the continuous variables are expressed
as the as mean values ± SDs. ˚C: Celsuis degree; bpm: beat per minute; COPD: chronic obstructive pulmonary
disease; CT: computed tomography; mmHg: millimeter of mercury.
https://doi.org/10.1371/journal.pone.0241407.t001
PLOS ONE Low-dose chest CT scoring for SARS-CoV-2 pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 5 / 12
(100%). On LDCT 23 patients showed no abnormalities (28%), 56 patients demonstrated GGOs
(67%), 21 patients had areas of consolidation (25%). An exclusive peripheral distribution was
found in 33 patients (40%). Only 9 patients showed crazy paving patterns (11%) (Fig 2).
COVID19-LDCT-score
The mean COVID19-LDCT score was 19 ± 28 with a mean right lung score of 10 ± 15 and a
mean left lung score of 8 ± 15 (Table 2). A significant correlation was found between the
Fig 2. Chest CT of patients with laboratory-proven COVID-19 pneumonia and paucisymptomatic patients.
Minimal form (a-c): Axial (a,b) and frontal reconstructions (c) of patchy ground-glass opacities (white arrows) with
segmental parenchyma involvement of 1 to 3 patchy lesions. Intermediate form (d-f): Axial (d,e) and frontal
reconstructions (f) of patchy ground-glass opacities (white arrows), band-like appearance (dotted arrow), and areas of
consolidation (arrowheads) with involvement less than 50%. Severe form (g-i): Axial (g,h) and frontal reconstructions
(i) of patchy ground-glass opacities (white arrows), band-like appearance (dotted arrow), and areas of consolidation
(arrowheads) with an involvement greater than 50%.
https://doi.org/10.1371/journal.pone.0241407.g002
Table 2. Imaging data.
Total Population
Imaging data
Dose x length product (mGy.cm) 41.7 ± 15.5 [30.1–100.1]
GGOs 56/80; 67%
Consolidation 21/80; 25%
Exclusively peripheral lesions 33/80; 40%
Crazy paving patterns 9/80; 11%
Normal imaging 23/80; 28%
Pleural effusions 4/80; 5%
Mediastinal nodes 4/80; 5%
COVID19-LDCT score
Lung score 19 ± 29 [0–161]
Note: The qualitative variables are expressed as figures with percentages, and the continuous variables are expressed
as the mean values ± SDs. GGOs: ground-glass opacities; LDCT: Low-dose computed tomography.
https://doi.org/10.1371/journal.pone.0241407.t002
PLOS ONE Low-dose chest CT scoring for SARS-CoV-2 pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 6 / 12
NEWS and the COVID19-LDCT score (r = 0.48, p<0.001). The correlation was also signifi-
cant for the right lung and the left lung (Fig 3).
No clinical symptoms were significant risk factors to find abnormalities on LDCT and espe-
cially cough was not a relevant clinical symptom to determine if patients had risk to have lung
involvement on LDCT.
Mean pulse oxymetry show a tendency to decrease in patient with pneumonia on LDCT
than without pneumonia: 97.6% ± 1.9 [92.0–100.0] and 96.9% ± 2.1 [91.0–100.0] respectively
(p = 0.07). Dyspnea was found in 11/80 cases. Over 69 patients without dyspnea 47 have an
abnormal LDCT and 22 were normal. Patients with normal LDCT showed a higher pulse oxy-
metry 98.0% ± 1.4 [95.0–100.0] compared to patient with pneumonia on LDCT 97.2% ± 1.8
[91.0–100.0] (p = 0.028) (Fig 4).
Score NEWS
Sixty-nine patients were classified as having low NEWS, and 11 patients had high NEWS. The
COVID-LDCT score was 13 ± 19 in the low-NEWS group and was significantly higher in the
high-NEWS group (52 ± 52; p = 0.001).
There was no significant difference between groups according to their symptoms or blood
pressure at the time of admittance. Patients with a NEWS > 4 had a significantly higher tem-
perature, heart rate, and respiratory rate and a lower oxygen saturation than patients with a
low NEWS (38.3˚C ± 1.0 versus 37.3˚C ± 0.8; p< 0.0001, 95 bpm ± 8 versus 81 bpm ± 12;
p<0.0001, 25/min ± 9 versus 18/min ± 4; p< 0.0001, 94% ± 2 versus 98% ± 2; p< 0.0001;
respectively). Oxygen was needed in 7 of 11 patients (64%) in the high-NEWS group and in 3
of 69 patients (7%) in the low-NEWS group (Table 3). The clinical factors associated with high
COVID19-LDCT Score in univariable analysis were diabetes (OR = 6.9 [1.32–36.2], p = 0.02),
Fig 3. Correlation between the NEWS and COVID19-LDCT score. A significant correlation was found. Pearson
coefficient = 0.48; p< 0.001.
https://doi.org/10.1371/journal.pone.0241407.g003
PLOS ONE Low-dose chest CT scoring for SARS-CoV-2 pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 7 / 12
hypertension (OR = 7.20 [1.22–42.5], p = 0.03), dyspnoea (OR = 7.65 [1.66–35.3], p = 0.01)
and respiratory rate (OR = 1.15 [1.03–1.30], p = 0.02). Because of the limited number of
patients with high COVID19-LDCT score and the sample size, no multivariable analysis was
performed.
Discussion
The main findings of the presented work are that 1) LDCT scans can depict the typical features
of SARS-CoV-2 pneumonia with limited irradiation; and 2) the COVID19-LDCT score is cor-
related with the NEWS used routinely to assess disease severity and patient prognosis.
Fig 4. Pulse oxymetry according to LDCT and dyspnea. A significant difference was found between pneumonia and non pneumonia on LDCT concerning
the oxymetry (p = 0.07) and between pneumonia and non pneumonia on LDCT among patient without dyspnea (p = 0.028). LDCT: low dose computed
tomography.
https://doi.org/10.1371/journal.pone.0241407.g004
Table 3. Low- and high-risk groups.
Low-risk patients High-risk patients
Clinical data’s NEWS 0–4 N = 69 NEWS >4 N = 11
Symptoms 64/69; 93% 11/11; 100%
Temperature (˚C) 37.3 ± 0.8 [35.8–39.5] 38.3 ± 1.0 [36.5–40.0] p < 0.001
Heart rate (bpm) 81 ± 12 [53–110] 95 ± 8 [80.0–105.0] p < 0.001
Systolic blood pressure (mmHg) 134 ± 22 [100–219] 128 ± 18 [107–160] p = 0.501
Diastolic blood pressure (mmHg) 77 ± 14 [11–120] 72 ± 13 [50–90] p = 0.440
Respiratory rate (/min) 18 ± 4 [10–28] 25 ± 9 [8–36] p < 0.001
Oxygen saturation (%) 98 ± 2 [92–100] 94 ± 2 [91–98] p < 0.001
Oxygen need 3/69; 4% 7/11; 64% p < 0.001
COVID19-LDCT score
Lung score 13 ± 19 [0–80] 52 ± 52 [3–161] P = 0.001
Note: The qualitative variables are expressed as figures with percentages, and the continuous variables are expressed as the mean values ± SDs. ˚C: Celsuis degree; bpm:
beat per minute; LDCT: low-dose computed tomography; mmHg: millimeter of mercury.
https://doi.org/10.1371/journal.pone.0241407.t003
PLOS ONE Low-dose chest CT scoring for SARS-CoV-2 pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 8 / 12
Unenhanced chest CT was performed using a low-dose acquisition protocol. All the CT
scans performed allowed optimal analysis of parenchyma involvement. Recently, recommen-
dations have been made regarding the use of LDCT for COVID19 that indicate preference for
LDCT [15]. They reported a mean dose-length product of 14.4 mGy.cm. A patient with
COVID-19 pneumonia could have 3 to 6 chest CT scans in a short period of time, and a
healthy patient could have 1 or 2 chest CT scans to ensure that they did not have COVID-19
[16]. Irradiation awareness is needed, especially for younger patients [17]. The present study
showed that CT image quality using LDCT is sufficient for depicting all the typical features of
COVID-19 pneumopathy. Acquisition parameters settings should be adapted to each patient
to maintain good contrast-to-noise ratio and signal-to-noise ratio, allowing adequate quality
of the lung parenchyma images [18]. Debray et al. have already shown in patients with lung
transplantation that the use of LDCT could be interesting to decrease global irradiation
because of repeated imaging for follow-up [19]. However, in patients with COVID-19 an
enhanced chest CT scan might be required for patients with clinical worsening considering an
over-risk of pulmonary embolism caused by inflammatory syndrome and bed rest.
As recently described, the clinico-radiological correlation is good, and diffuse lung involve-
ment is frequently observed in severe forms [20, 21]. Lesions extent is higher in patients with a
need for intensive care units than for ordinary units. In particular, lymph nodes and pleural
effusion are highly frequent in severe patients. The present paper is in favor of a correlation
between disease extent and clinical severity. There are some patients with a RT-PCR positive
result and a normal chest CT 23 of 80 (28%), that is not consistent with the whole studies on
CT scan sensitivity. We explained that because patients came from a screening center and
some patients are tested because they are contact case with infected patients. The sensitivity of
the CT scan depends on the level of pre-test risk of the population to present lung involvement.
Disappointingly, we did not highlight any symptoms that could predict pulmonary involve-
ment, particularly cough, which is generally one of the main symptoms of manifestations of
alveolar involvement. It is in line with a recent publication from Yang et al. showing that
patients could be COVID-19 infected and had few or no clinical symptoms with a normal
chest CT and/or negative RT-PCR test [22].
The COVID19-LDCT score may provide the quantitative measurement of COVID-19
injury. Patients can be easily classified in various degrees of the disease. This type of CT score
was first described in 2004 for severe acute respiratory syndrome (SARS). Investigators divided
each lung into 3 parts (upper, middle and lower) and evaluated the involvement on a scale of
0–4: 0, <25%, 25–50>50% and>75% involvement: the maximum possible score was 24 [23].
The present approach uses the simplest scale, comprising 3 kinds of impairment: minimal,
intermediate, and severe. It focuses on the anatomical distribution of lesions based on segmen-
tal analysis. This scoring system is based on the decreased in lung function applayed in tho-
racic surgery. It has been shown that wedge resection spare parenchyma loss more than
segmentectomy and segmentectomy more than lobectomy [24]. We guess that a minimal
involvement will have only few consequences on hematosis and more than 50% of segment
involvement seems lead to a total shunt effect and we grade it 10. The score over 50/200 had
been arbitrary chosen for severe involvement because that mean involvement of 50% of the
lung corresponding to a lobectomy. Patients with comorbidities such as emphysema or former
thoracic surgery have a higher risk of death in case of lobectomy [25]. We considered that a
score > 50/200 could lead to death according to the cormobidities and need to classify patients
in the severe group.
There are a few limitations in the present study. Our population was mainly paucisympto-
matic patients which did not allow us to have a wide repartition of NEWS and CT scores for
correlation, especially for high scores. This could be explained because we enrolled the 80 first
PLOS ONE Low-dose chest CT scoring for SARS-CoV-2 pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 9 / 12
patients with COVID-19 pneumonia in our centre and the severe forms are not the most fre-
quent. Another limit is the low number of patient that does not allowed us to perform a multi-
variate analysis and further studies are needed to establish this score a clinical prognosis tool.
Low-dose CT scan could depict the typical features of COVID-19 pneumonia. In this popu-
lation of 80 COVID-19 patients detected positive by RT-PCR, there was a significant correla-
tion between the clinical NEWS and the COVID19-LDCT score, showing the close
relationship between signs and the extent of disease in the lung. More work is required to
assess whether this score could add clinically relevant information to assess the prognosis of
patients with COVID-19 pneumonia.
Supporting information
S1 File. IRB.
(PDF)
S1 Data.
(XLSX)
Acknowledgments
We would like to thank all the technicians for their professionalism during this crisis. Thanks
to health managers to the optimal organization of workflow in the department.
Author Contributions
Conceptualization: Alexis Jacquier, Jean-Yves Gaubert.
Data curation: Maxime Castelli, Julie Finance, Axel Bartoli.
Formal analysis: Pierre-Antoine Barral, Paul Habert.
Investigation: Thomas Leger, Alexis Jacquier, Jean-Christophe Lagier, Matthieu Million, Phi-
lippe Parola, Philippe Brouqui, Axel Bartoli.
Methodology: Philippe Parola.
Project administration: Alexis Jacquier, Jean-Yves Gaubert, Paul Habert.
Resources: Jean-Christophe Lagier, Matthieu Million, Philippe Parola, Philippe Brouqui,
Didier Raoult, Axel Bartoli.
Validation: Alexis Jacquier, Jean-Yves Gaubert.
Visualization: Thomas Leger, Alexis Jacquier, Pierre-Antoine Barral, Jean-Christophe Lagier,
Matthieu Million, Philippe Parola, Philippe Brouqui, Didier Raoult, Paul Habert.
Writing – original draft: Thomas Leger, Paul Habert.
Writing – review & editing: Thomas Leger, Alexis Jacquier, Didier Raoult, Jean-Yves Gaubert,
Paul Habert.
References1. Munster VJ, Koopmans M, van Doremalen N, van Riel D, de Wit E. A novel coronavirus emerging in
China—key questions for impact assessment. N Engl J Med. 2020; 382(8):692–694. https://doi.org/10.
1056/NEJMp2000929 PMID: 31978293
2. Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel
coronavirus in Wuhan, China. Lancet Lond Engl. 15 2020; 395(10223):497–506.
PLOS ONE Low-dose chest CT scoring for SARS-CoV-2 pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 10 / 12
3. Ai T, Yang Z, Hou H, Zhan C, Chen C, Lv W, et al. Correlation of chest CT and RT-PCR testing in coro-
navirus disease 2019 (COVID-19) in China: a report of 1014 cases. Radiology. 26 fevr 2020;200642.
https://doi.org/10.1148/radiol.2020200642 PMID: 32101510
4. Chen Z, Li Y, Wu B, Hou Y, Bao J, Deng X. A patient with COVID-19 presenting a false-negative reverse
transcriptase polymerase chain reaction result. Korean J Radiol [Internet]. 2020 [cite 25 mars 2020];21.
Disponible sur: https://www.kjronline.org/DOIx.php?id=10.3348/kjr.2020.0195 PMID: 32207257
5. Fang Y, Zhang H, Xie J, Lin M, Ying L, Pang P, et al. Sensitivity of chest CT for COVID-19: comparison
to RT-PCR. Radiology. 2020;200432. https://doi.org/10.1148/radiol.2020200432 PMID: 32073353
6. Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel
coronavirus (2019-nCoV). Radiology. avr 2020; 295(1):202–7. https://doi.org/10.1148/radiol.
2020200230 PMID: 32017661
7. Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X, et al. Clinical and high-resolution CT features of the COVID-
19 infection: comparison of the initial and follow-up changes. Invest Radiol. 3 mars 2020. https://doi.org/
10.1097/RLI.0000000000000674 PMID: 32134800
8. Wang Y, Dong C, Hu Y, Li C, Ren Q, Zhang X, et al. Temporal changes of CT findings in 90 patients
with COVID-19 pneumonia: a longitudinal study. Radiology. 19 mars 2020;200843. https://doi.org/10.
1148/radiol.2020200843 PMID: 32191587
9. Amrane S, Tissot-Dupont H, Doudier B, Eldin C, Hocquart M, Mailhe M, et al. Rapid viral diagnosis and
ambulatory management of suspected COVID-19 cases presenting at the infectious diseases referral
hospital in Marseille, France,—January 31st to March 1st, 2020: A respiratory virus snapshot. Travel
Med Infect Dis. mars 2020;101632. https://doi.org/10.1016/j.tmaid.2020.101632 PMID: 32205269
10. Smith GB, Prytherch DR, Meredith P, Schmidt PE, Featherstone PI. The ability of the National Early
Warning Score (NEWS) to discriminate patients at risk of early cardiac arrest, unanticipated intensive
care unit admission, and death. Resuscitation. avr 2013; 84(4):465–70. https://doi.org/10.1016/j.
resuscitation.2012.12.016 PMID: 23295778
11. Hansell DM, Bankier AA, MacMahon H, McLoud TC, Muller NL, Remy J. Fleischner Society: glossary
of terms for thoracic imaging. Radiology. mars 2008; 246(3):697–722. https://doi.org/10.1148/radiol.
2462070712 PMID: 18195376
12. Cheng Z, Lu Y, Cao Q, Qin L, Pan Z, Yan F, et al. Clinical features and chest CT manifestations of coro-
navirus disease 2019 (COVID-19) in a single-center study in Shanghai, China. Am J Roentgenol. 14
mars 2020;1–6.
13. Ye Z, Zhang Y, Wang Y, Huang Z, Song B. Chest CT manifestations of new coronavirus disease 2019
(COVID-19): a pictorial review. Eur Radiol [Internet]. 19 mars 2020; Disponible sur: https://doi.org/10.
1007/s00330-020-06801-0 PMID: 32193638
14. Lagier JC, Colson P, Tissot Dupont H, Salomon J, Doudier B, Aubry C, et al. Testing the repatriated for
SARS-Cov2: Should laboratory-based quarantine replace traditional quarantine? Travel Med Infect Dis.
14 mars 2020;101624. https://doi.org/10.1016/j.tmaid.2020.101624 PMID: 32179125
15. Kang Z, Li X, Zhou S. Recommendation of low-dose CT in the detection and management of COVID-
2019. Eur Radiol [Internet]. 19 mars 2020 [cite 25 mars 2020]; Disponible sur: https://doi.org/10.1007/
s00330-020-06809-6 PMID: 32193637
16. Lei DP. The progression of computed tomographic (CT) images in patients with coronavirus disease
(COVID-19) pneumonia: the CT progression of COVID-19 pneumonia. J Infect [Internet]. 20 mars 2020
[cite 25 mars 2020];0(0). Disponible sur: https://www.journalofinfection.com/article/S0163-4453(20)
30151-1/abstract PMID: 32205140
17. Taqi AH, Faraj KA, Zaynal SA. The Effect of Long-term x-ray exposure on human lymphocyte. J Biomed
Phys Eng. 1 fevr 2019; 9(1):127–32. PMID: 30881942
18. Martini K, Moon JW, Revel MP, Dangeard S, Ruan C, Chassagnon G. Optimization of acquisition
parameters for reduced-dose thoracic CT: A phantom study. Diagn Interv Imaging. 24 fevr 2020. https://
doi.org/10.1016/j.diii.2020.01.012 PMID: 32107196
19. Debray M-P, Dauriat G, Khalil A, Leygnac S, Tubiana S, Grandjean A, et al. Diagnostic accuracy of low-
mA chest CT reconstructed with Model Based Iterative Reconstruction in the detection of early pleuro-
pulmonary complications following a lung transplantation. Eur Radiol. sept 2016; 26(9):3138–46.
https://doi.org/10.1007/s00330-015-4126-0 PMID: 26645864
20. Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT findings and clinical conditions of coro-
navirus disease (COVID-19) pneumonia: a multicenter study. Am J Roentgenol. 3 mars 2020;1–6.
https://doi.org/10.2214/AJR.20.22976 PMID: 32125873
21. Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, et al. The clinical and chest CT features associated with
severe and critical COVID-19 pneumonia. Invest Radiol. 29 fevr 2020. https://doi.org/10.1097/RLI.
0000000000000672 PMID: 32118615
PLOS ONE Low-dose chest CT scoring for SARS-CoV-2 pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 11 / 12
22. Yang W, Yan F. Patients with RT-PCR confirmed COVID-19 and normal chest CT | Radiology [Internet].
2020 [cite 31 mars 2020]. Disponible sur: https://pubs.rsna.org/doi/10.1148/radiol.2020200702?url_
ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
23. Ooi GC, Khong PL, Muller NL, Yiu WC, Zhou LJ, Ho JCM, et al. Severe acute respiratory syndrome:
temporal lung changes at thin-section CT in 30 patients. Radiology. mars 2004; 230(3):836–44. https://
doi.org/10.1148/radiol.2303030853 PMID: 14990845
24. Dziedzic R, Rzyman W. Lobectomy versus segmentectomy and wedge resection in the treatment of
stage I non-small cell lung cancer. J Thorac Dis. mars 2018; 10(3):E234–5. https://doi.org/10.21037/jtd.
2018.03.30 PMID: 29708140
25. Nakada T, Noda Y, Kato D, Shibasaki T, Mori S, Asano H, et al. Risk factors and cancer recurrence
associated with postoperative complications after thoracoscopic lobectomy for clinical stage I non-small
cell lung cancer. Thorac Cancer. oct 2019; 10(10):1945–52. https://doi.org/10.1111/1759-7714.13173
PMID: 31436042
PLOS ONE Low-dose chest CT scoring for SARS-CoV-2 pneumonia
PLOS ONE | https://doi.org/10.1371/journal.pone.0241407 November 3, 2020 12 / 12